(Q48959345)

17 February 2018

title

Renal sympathetic denervation: the jury is still out. (English)

1 reference

17 February 2018

author name string

Michael Doumas

series ordinal

1

1 reference

17 February 2018

Stella Douma

series ordinal

2

1 reference

17 February 2018

language of work or name

English

0 references

publication date

17 November 2010

1 reference

17 February 2018

published in

The Lancet

1 reference

17 February 2018

volume

376

1 reference

17 February 2018

issue

9756

1 reference

17 February 2018

page(s)

1878-1880

1 reference

17 February 2018

Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2962111-3

7 January 2021

Interventional management of resistant hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2962111-3

7 January 2021

Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2962111-3

7 January 2021

Resistant hypertension: an overview of evaluation and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2962111-3

7 January 2021

Resistant hypertension: an unmet treatment need

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2962111-3

7 January 2021

A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2962111-3

7 January 2021

Divergent results using clinic and ambulatory blood pressures: report of a darusentan-resistant hypertension trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2962111-3

7 January 2021

Novel baroreflex activation therapy in resistant hypertension: results of a European multi-center feasibility study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2962111-3

7 January 2021

Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2962111-3

7 January 2021

Renal sympathetic denervation and systemic hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2962111-3

7 January 2021

Hypertension and its surgical treatment by bilateral supradiaphragmatic splanchnicectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2962111-3

7 January 2021

10.1016/S0140-6736(10)62111-3

Identifiers

DOI

1 reference

17 February 2018

1 reference

17 February 2018